These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8247308)

  • 1. [Antihypertensive action of nicardipine retard in 24 hours and its effect on stress].
    De Cesaris R; Ranieri G; Andriani A; Filitti V; Bonfantino MV; Lamontanara G; Ferrieri A
    Minerva Med; 1993 Oct; 84(10):533-9. PubMed ID: 8247308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Slow-release nicardipine in the treatment of arterial hypertension: comparative study vs. an ACE inhibitor].
    De Cesaris R; Ranieri G; Bonfantino V; Adriani A; Filitti V; Ferrieri A
    Minerva Cardioangiol; 1993 Oct; 41(10):457-63. PubMed ID: 8302442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerability of nicardipine retard and captopril in hypertension in the aged. Results of a multicenter study].
    Mancia G; Buoninconti R; Errico M; Freda M; Giordano MP; Granata Q; Lucentini ML; Marsili P; Pasotti C; Piccolo E
    Minerva Med; 1992 Nov; 83(11):731-8. PubMed ID: 1461544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on casual and 24-h ambulatory blood pressure of slow-release nicardipine and chlorthalidone in arterial essential hypertension: double-blind, crossover study.
    Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Divitiis O
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):190-6. PubMed ID: 2365538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrendipine once daily compared with nicardipine in the treatment of mild to moderate hypertension.
    Palermo R; Conti V; Agostinelli MC; Ganzetti S; Racco F; Melappioni A; Pratillo G; Moretti S
    Clin Ther; 1990; 12(2):149-56. PubMed ID: 2354484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem vs. nicardipine on ambulatory and exercise blood pressure and on peripheral hemodynamics.
    Palatini P; Casiglia E; Graniero GR; Dorigatti F; Lotoro F; Vriz O; Pessina AC
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):38-42. PubMed ID: 7711991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension].
    Benvenuti C; Guerini Rocco C; Trezzi P
    Minerva Cardioangiol; 1995 Sep; 43(9):399-408. PubMed ID: 8552269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice-daily nicardipine in the treatment of essential hypertension.
    Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
    J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicardipine retard in the therapy of elderly diabetic hypertensives: final report of observational study.
    Antonicelli R; Pagelli P; Paciaroni E
    J Hypertens Suppl; 1992 Apr; 10(2):S69-72. PubMed ID: 1593306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and tolerance of LA 50 mg nicardipine in hypertensive athletes].
    Marcadet DM; Blanc AS; Lopez AA; Preziosi JP; Guignard MM; Baggio S; Sassano P
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1569-74. PubMed ID: 1763923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise.
    Jones RI; Hornung RS; Sonecha T; Raftery EB
    J Hypertens; 1983 Jun; 1(1):85-9. PubMed ID: 6681029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of nicardipine in type 2 diabetic patients with slight hypertension.
    Faguer de Moustier B; Paoli V
    J Cardiovasc Pharmacol; 1990; 16 Suppl 2():S26-33. PubMed ID: 1369705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double-blind evaluation of slow-release nicardipine using different methods of blood pressure measurement. Predictive value of the acute response to intravenous nicardipine].
    Bellet B; Pagny JY; Chatellier G; Frère R; Ménard D; Corvol P; Ménard J
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):851-5. PubMed ID: 3116985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of essential hypertension with the alpha-1 antagonist bunazosin retard. A multicenter, double-blind, placebo-controlled study].
    Kirsten R; Weidinger G
    Arzneimittelforschung; 1994 Jan; 44(1):13-6. PubMed ID: 7907871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension].
    Melina D; Guerrera G; Santoliquido A; Colivicchi F; Melina G; Musumeci V; Guerrera C
    Clin Ter; 1991 Nov 15-30; 139(3-4):101-6. PubMed ID: 1837249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and arrhythmias: effects of slow-release nicardipine vs chlorthalidone: a double-blind crossover study.
    Galderisi M; Celentano A; Tammaro P; Garofalo M; Mureddu GF; de Divitiis O
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):410-5. PubMed ID: 2258249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isoptin-Retard 240 mg in the treatment of mild and moderate arterial hypertension].
    Arabidze GG; Rogoza AN; Dmitriev VV; Metelitsa TV; Domba GIu; Sitina VK
    Ter Arkh; 1993; 65(9):50-2. PubMed ID: 8303597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.